We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CTAS:NASDAQCintas Corporation Analysis

Data as of 2026-03-27 - not real-time

$168.85

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Cintas’ stock is trading at $168.85, well below its 20‑day ($191.6), 50‑day ($193.6) and 200‑day ($200.1) simple moving averages, signaling a bearish technical backdrop. The RSI of 21.5 places the security in oversold territory, while a bearish MACD histogram (-2.69) and a price hovering just above the identified support level of $168.02 suggest limited downside but heightened volatility, as evidenced by a 30‑day price swing of roughly 25%.
On the fundamentals side, CTAS delivered an 8.9% revenue jump to $2.84 B in Q3 2026, maintaining strong gross (50.4%) and operating (23.2%) margins and an exceptional ROE of 41.3%. The forward‑looking EPS of $5.43 and a forward P/E of 31.1 remain above the industry average P/E of 28.5, indicating the stock is priced for growth. The $5.5 B cash‑and‑stock acquisition of UniFirst, projected to add $375 M in synergies, provides a clear growth catalyst, while a 1.07% dividend yield with a 36.7% payout ratio appears sustainable given robust cash flows. Analyst consensus (median target $213) still implies upside of ~26% from current levels, despite the DCF‑derived fair value of $67.3 suggesting the market may be overvaluing the business relative to discounted cash‑flow expectations.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price near technical support with oversold RSI
  • High short‑term volatility and bearish trend indicators
  • Uncertainty around timing of UniFirst integration

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Projected $375 M synergies from UniFirst acquisition
  • Sustained revenue growth and strong operating margins
  • Analyst price targets indicating ~26% upside

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Robust ROE (41%) and cash flow generation
  • Dividend yield with a comfortable payout ratio
  • Long‑term secular demand for uniform and safety services

Key Metrics & Analysis

Financial Health

Revenue Growth8.90%
Profit Margin17.57%
P/E Ratio35.6
ROE41.30%
ROA15.94%
Debt/Equity60.94
P/B Ratio14.1
Op. Cash Flow$2.2B
Free Cash Flow$1.5B
Industry P/E28.5

Technical Analysis

TrendBearish
RSI21.5
Support$168.02
Resistance$209.08
MA 20$191.64
MA 50$193.56
MA 200$200.07
MACDBearish
VolumeIncreasing
Fear & Greed Index71.79

Valuation

Fair Value$67.27
Target Price$214.24
Upside/Downside26.88%
GradeOvervalued
TypeBlend
Dividend Yield1.07%

Risk Assessment

Beta0.64
Volatility25.03%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.